Effects of Pyridine Ring Substitutions on Affinity, Efficacy, and Subtype Selectivity of Neuronal Nicotinic Receptor Agonist Epibatidine
- 1 January 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 302 (3) , 1246-1252
- https://doi.org/10.1124/jpet.102.035899
Abstract
2'-Pyridine ring substituted analogs of epibatidine were assessed for equilibrium binding affinity, functional potency, and efficacy at rat neuronal nicotinic receptors expressed in Xenopus oocytes. Binding affinities were determined in membrane homogenates from oocytes expressing alpha2beta2, alpha2beta4, alpha3beta2, alpha3beta4, alpha4beta2, or alpha4beta4. Efficacy (relative to acetylcholine) and potency were measured electrophysiologically with oocytes expressing alpha3beta4, alpha4beta2, and alpha4beta4. Hydroxy, dimethylamino, and trifluoromethanesulfonate analogs had affinities too low for accurate measurement. The bromo analog had affinities 4- to 55-fold greater at beta2 than at beta4-containing receptors, modestly greater efficacy at alpha4beta4 than at alpha4beta2, and 5- to 10-fold greater potency at a4beta4 than at alpha3beta4 or alpha4beta2. The fluoro analog displayed affinities 52- to 875-fold greater at beta2- than at beta4-containing receptors, efficacy at alpha4beta4 receptors 3-fold greater than at alpha4beta2 and alpha3beta4, and was equipotent at all receptors tested. The norchloro analog showed affinities 114- to 3500-fold greater at beta2- than at beta4-containing receptors, 2-fold greater efficacy at alpha4beta2 and alpha4beta4 than at alpha3beta4, and 4- to 5-fold greater potency at alpha4beta4 and alpha3beta4 than at alpha4beta2. The amino analog displayed affinities 10- to 115-fold greater at beta2- than at beta4-containing receptors, 3-fold greater efficacy at alpha3beta4 than at alpha4beta2, and 2- to 4-fold greater potency at alpha3beta4 and alpha4beta4 than at alpha4beta2. Although these compounds displayed a variety of differences in affinity, efficacy, and potency, with one exception (binding affinity and functional potency at alpha4beta4 receptors) there were no significant correlations among these properties.Keywords
This publication has 20 references indexed in Scilit:
- Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 2-exo-2-(2‘-Substituted 5‘-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine AnaloguesJournal of Medicinal Chemistry, 2001
- α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cellsProceedings of the National Academy of Sciences, 2001
- The unusual nature of epibatidine responses at the α4β2 nicotinic acetylcholine receptorNeuropharmacology, 2000
- Nicotinic Receptors at the Amino Acid LevelAnnual Review of Pharmacology and Toxicology, 2000
- Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brainMolecular Brain Research, 1999
- Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidineEuropean Journal of Pharmacology, 1997
- Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor β SubunitsJournal of Neuroscience, 1996
- The Pharmacology of (-)-Nicotine and Novel Cholinergic Channel ModulatorsPublished by Elsevier ,1996
- Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for cns therapeuticsLife Sciences, 1995
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973